Vimseltinib

ROMVIMZA 20 mg harde capsules

Capsule, hardNetherlandsAuthorisedAuthorised 17 Sept 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

RomvimzaEuropean UnionAuthorised

Romvimza 14 MG Capsulas DurasSpain · 14 mg · cápsula dura · Deciphera Pharmaceuticals (Netherlands) B.V.Same brand
Romvimza 20 MG Capsulas DurasSpain · 21,68 mg · cápsula dura · Deciphera Pharmaceuticals (Netherlands) B.V.Same brand
Romvimza 30 MG Capsulas DurasSpain · 30 mg · cápsula dura · Deciphera Pharmaceuticals (Netherlands) B.V.Same brand
RomvimzaEuropean Union · Deciphera Pharmaceuticals (Netherlands) B.V.Same brand
RomvimzaCroatiaSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Vimseltinib

ROMVIMZA 20 mg harde capsules

Capsule, hardNetherlandsAuthorisedAuthorised 17 Sept 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

RomvimzaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Romvimza

Italy · Capsula rigida · Deciphera Pharmaceuticals (Netherlands) B.V.

RomvimzaUnited States · 14MG, 20MG, 30MG · capsule · Deciphera Pharms

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Vimseltinib
Dosage form: Capsule, hard
Route: Oraal gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 17 Sept 2025
Registration: EU/1/25/1968
Marketing authorisation holder: Deciphera Pharmaceuticals (Netherlands) B.V.
ATC code: L01EX29
Group: Antineoplastic and immunomodulating agents
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/006363
EU number: EU/1/25/1968